Skip to main content
SpringerLink
Log in

Adenosine Triphosphate

Established and Potential Clinical Applications

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Adenosine 5′-triphosphate (ATP) is a purine nucleotide found in every cell of the human body. In addition to its well established role in cellular metabolism, extracellular ATP and its breakdown product adenosine, exert pronounced effects in a variety of biological processes including neurotransmission, muscle contraction, cardiac function, platelet function, vasodilatation and liver glycogen metabolism. These effects are mediated by both P1 and P2 receptors. A cascade of ectonucleotidases plays a role in the effective regulation of these processes and may also have a protective function by keeping extracellular ATP and adenosine levels within physiological limits. In recent years several clinical applications of ATP and adenosine have been reported. In anaesthesia, low dose adenosine reduced neuropathic pain, hyperalgesia and ischaemic pain to a similar degree as morphine or ketamine. Postoperative opioid use was reduced. During surgery, ATP and adenosine have been used to induce hypotension. In patients with haemorrhagic shock, increased survival was observed after ATP treatment. In cardiology, ATP has been shown to be a well tolerated and effective pulmonary vasodilator in patients with pulmonary hypertension. Bolus injections of ATP and adenosine are useful in the diagnosis and treatment of paroxysmal supraventricular tachycardias. Adenosine also allowed highly accurate diagnosis of coronary artery disease. In pulmonology, nucleotides in combination with a sodium channel blocker improved mucociliary clearance from the airways to near normal in patients with cystic fibrosis. In oncology, there are indications that ATP may inhibit weight loss and tumour growth in patients with advanced lung cancer. There are also indications of potentiating effects of cytostatics and protective effects against radiation tissue damage. Further controlled clinical trials are warranted to determine the full beneficial potential of ATP, adenosine and uridine 5′-triphosphate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Forrester T, Lind AR. Identification of adenosine triphosphate in human plasma and the concentration in the venous effluent of forearm muscles before, during and after sustained contractions. J Physiol (Lond) 1969; 204(2): 347–64

    CAS  Google Scholar 

  2. Fredholm BB, Abbracchio MP, Burnstock G, et al. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 1997; 18(3): 79–82

    Article  PubMed  CAS  Google Scholar 

  3. Feoktistov I, Polosa R, Holgate ST, et al. Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 1998; 19: 148–53

    Article  PubMed  CAS  Google Scholar 

  4. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 1994; 64(3): 445–75

    Article  PubMed  CAS  Google Scholar 

  5. Dubyak GR, el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993; 265(3): C577–606

    PubMed  CAS  Google Scholar 

  6. Conigrave AD, Jiang L. Review: Ca2+-mobilizing receptors for ATP and UTP. Cell Calcium 1995; 17(2): 111–9

    Article  PubMed  CAS  Google Scholar 

  7. Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 1994; 140(1): 1–22

    Article  PubMed  CAS  Google Scholar 

  8. Torrance JD, Whittaker D. Distribution of erythrocyte nucleotides in pyrimidine 5′-nucleotidase deficiency. Br J Haematol 1979; 43(3): 423–34

    Article  PubMed  CAS  Google Scholar 

  9. de Korte D, Haverkort WA, van Gennip AH, et al. Nucleotide profiles of normal human blood cells determined by high-performance liquid chromatography. Anal Biochem 1985; 147(1): 197–209

    Article  PubMed  Google Scholar 

  10. Werner A, Siems W, Schmidt H, et al. Determination of nucleotides, nucleosides and nucleobases in cells of different complexity by reversed-phase and ion-pair high-performance liquid chromatography. J Chromatogr 1987; 421(2): 257–65

    PubMed  CAS  Google Scholar 

  11. Harkness RA, Simmonds RJ, Coade SB. Purine transport and metabolism in man: the effect of exercise on concentrations of purine bases, nucleosides and nucleotides in plasma, urine, leucocytes and erythrocytes. Clin Sci 1983; 64(3): 333–40

    PubMed  CAS  Google Scholar 

  12. Ryan LM, Rachow JW, McCarty BA, et al. Adenosine triphosphate levels in human plasma. J Rheumatol 1996; 23(2): 214–9

    PubMed  CAS  Google Scholar 

  13. Ontyd J, Schrader J. Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr 1984; 307(2): 404–9

    PubMed  CAS  Google Scholar 

  14. Parker JC. Metabolism of external adenine nucleotides by human red blood cells. Am J Physiol 1970; 218(6): 1568–74

    PubMed  CAS  Google Scholar 

  15. Schrader J, Berne RM, Rubio R. Uptake and metabolism of adenosine by human erythrocyte ghosts. Am J Physiol 1972; 223(1): 159–66

    PubMed  CAS  Google Scholar 

  16. Trams EG. A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol 1980; 87(3): 609–21

    Article  PubMed  CAS  Google Scholar 

  17. Haskell CM, Wong M, Williams A, et al. Phase I trial of extracellular adenosine 5′-triphosphate in patients with advanced cancer. Med Pediatr Oncol 1996; 27(3): 165–73

    Article  PubMed  CAS  Google Scholar 

  18. Rapaport E, Fontaine J. Generation of extracellular ATP in blood and its mediated inhibition of host weight loss in tumor-bearing mice. Biochem Pharmacol 1989; 38(23): 4261–6

    Article  PubMed  CAS  Google Scholar 

  19. Lerner MH, Lowy BA. The formation of adenosine in rabbit liver and its possible role as a direct precursor of erythrocyte adenine nucleotides. J Biol Chem 1974; 249(3): 959–66

    PubMed  CAS  Google Scholar 

  20. Rapaport E, Fontaine J. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc Natl Acad Sci U S A 1989; 86(5): 1662–6

    Article  PubMed  CAS  Google Scholar 

  21. Rapaport E. Experimental cancer therapy in mice by adenine nucleotides. Eur J Cancer Clin Oncol 1988; 24(9): 1491–7

    Article  PubMed  CAS  Google Scholar 

  22. Rapaport E. Mechanisms of anticancer activities of adenine nucleotides in tumor-bearing hosts. Ann N Y Acad Sci 1990; 603: 142–9

    Article  PubMed  CAS  Google Scholar 

  23. Shapiro MJ, Jellinek M, Pyrros D, et al. Clearance and maintenance of blood nucleotide levels with adenosine triphosphate-magnesium chloride injection. Circ Shock 1992; 36(1): 62–7

    PubMed  CAS  Google Scholar 

  24. Binet L, Burstein M. Poumon et action vasculaire de l’adenosine-triphosphate (ATP). Presse Med 1950; 58(68): 1201–3

    PubMed  CAS  Google Scholar 

  25. Paddle BM, Burnstock G. Release of ATP from perfused heart during coronary vasodilatation. Blood Vessels 1974; 11(3): 110–9

    PubMed  CAS  Google Scholar 

  26. Ryan JW, Smith U. Metabolism of adenosine 5′-monophosphate during circulation through the lungs. Trans Assoc Am Physicians 1971; 134: 297–306

    Google Scholar 

  27. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989; 256(4): C799–806

    PubMed  CAS  Google Scholar 

  28. Ryan US, Ryan JW, Crutchley DJ. The pulmonary endothelial surface. Fed Proc 1985; 44(10): 2603–9

    PubMed  CAS  Google Scholar 

  29. Pearson JD, Carleton JS, Gordon JL. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 1980; 190(2): 421–9

    PubMed  CAS  Google Scholar 

  30. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986; 233(2): 309–19

    PubMed  CAS  Google Scholar 

  31. Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res 1989; 65(3): 531–7

    Article  PubMed  CAS  Google Scholar 

  32. Barankiewicz J, Dosch HM, Cohen A. Extracellular nucleotide catabolism in human B and T lymphocytes.: the source of adenosine production. J Biol Chem 1988; 263(15): 7094–8

    PubMed  CAS  Google Scholar 

  33. Filippini A, Taffs RE, Agui T, et al. Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP. J Biol Chem 1990; 265(1): 334–40

    CAS  Google Scholar 

  34. Schwarzbaum PJ, Frischmann ME, Krumschnabel G, et al. Functional role of ecto-ATPase activity in goldfish hepatocytes. Am J Physiol 1998; 274(4): R1031–8

    PubMed  CAS  Google Scholar 

  35. Gordon EL, Pearson JD, Slakey LL. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta: feed-forward inhibition of adenosine production at the cell surface. J Biol Chem 1986; 261(33): 15496–507

    PubMed  CAS  Google Scholar 

  36. Sawynok J, Sweeney MI. The role of purines in nociception. Neuroscience 1989; 32(3): 557–69

    Article  PubMed  CAS  Google Scholar 

  37. Sawynok J, Sweeney MI, White TD. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol Sci 1989; 10(5): 186–9

    Article  PubMed  CAS  Google Scholar 

  38. Salter MW, Henry JL. Effects of adenosine 5′-monophosphate and adenosine 5′-triphosphate on functionally identified units in the cat spinal dorsal horn. Evidence for a differential effect of adenosine 5′-triphosphate on nociceptive vs non-nociceptive units. Neuroscience 1985; 15(3): 815–25

    CAS  Google Scholar 

  39. Geiger JD, LaBella FS, Nagy JI. Characterization and localization of adenosine receptors in rat spinal cord. J Neurosci 1984; 4(9): 2303–10

    PubMed  CAS  Google Scholar 

  40. Choca JI, Proudfit HK, Green RD. Identification of A1 and A2 adenosine receptors in the rat spinal cord. J Pharmacol Exp Ther 1987; 242(3): 905–10

    PubMed  CAS  Google Scholar 

  41. Choca JI, Green RD, Proudfit HK. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J Pharmacol Exp Ther 1988; 247(2): 757–64

    PubMed  CAS  Google Scholar 

  42. Rice WR, Burton FM, Fiedeldey DT. Cloning and expression of the alveolar type II cell P2u-purinergic receptor. Am J Respir Cell Mol Biol 1995; 12(1): 27–32

    PubMed  CAS  Google Scholar 

  43. Gobran LI, Rooney SA. Adenylate cyclase-coupled ATP receptor and surfactant secretion in type II pneumocytes from newborn rats. Am J Physiol 1997; 272(2): L187–96

    PubMed  CAS  Google Scholar 

  44. Clarke LL, Boucher RC. Chloride secretory response to extracellular ATP in human normal and cystic fibrosis nasal epithelia. Am J Physiol 1992; 263(2): C348–56

    PubMed  CAS  Google Scholar 

  45. Clarke LL, Grubb BR, Yankaskas JR, et al. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr (−/−) mice. Proc Natl Acad Sci U S A 1994; 91(2): 479–83

    Article  PubMed  CAS  Google Scholar 

  46. Stutts MJ, Fitz JG, Paradiso AM, et al. Multiple modes of regulation of airway epithelial chloride secretion by extracellular ATP. Am J Physiol 1994; 267(5): C1442–51

    PubMed  CAS  Google Scholar 

  47. Cantiello HF, Prat AG, Reisin IL, et al. External ATP and its analogs activate the cystic fibrosis transmembrane conductance regulator by a cyclic AMP-independent mechanism. J Biol Chem 1994; 269(15): 11224–32

    PubMed  CAS  Google Scholar 

  48. Reisin IL, Prat AG, Abraham EH, et al. The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 1994; 269(32): 20584–91

    PubMed  CAS  Google Scholar 

  49. Reddy MM, Quinton PM. Hydrolytic and nonhydrolytic interactions in the ATP regulation of CFTR Cl-conductance. Am J Physiol 1996; 271(1): C35–42

    PubMed  CAS  Google Scholar 

  50. Knowles MR, Clarke LL, Boucher RC. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 1991; 325(8): 533–8

    Article  PubMed  CAS  Google Scholar 

  51. Mason SJ, Paradiso AM, Boucher RC. Regulation of trans-epithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br J Pharmacol 1991; 103(3): 1649–56

    Article  PubMed  CAS  Google Scholar 

  52. Lustig KD, Shiau AK, Brake AJ, et al. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A 1993; 90(11): 5113–7

    Article  PubMed  CAS  Google Scholar 

  53. Parr CE, Sullivan DM, Paradiso AM, et al. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci U S A 1994; 91(8): 3275–9

    Article  PubMed  CAS  Google Scholar 

  54. Communi D, Boeynaems JM. Receptors responsive to extracellular pyrimidine nucleotides. Trends Pharmacol Sci 1997; 18(3): 83–6

    Article  PubMed  CAS  Google Scholar 

  55. Abraham EH, Vos P, Kahn J, et al. Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth. Nat Med 1996; 2(5): 593–6

    Article  PubMed  CAS  Google Scholar 

  56. Abraham EH, Okunieff P, Scala S, et al. Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate. Science 1997; 275(5304): 1324–6

    Article  PubMed  CAS  Google Scholar 

  57. Reddy MM, Quinton PM, Haws C, et al. Failure of the cystic fibrosis transmembrane conductance regulator to conduct ATP. Science 1996; 271(5257): 1876–9

    Article  PubMed  CAS  Google Scholar 

  58. Di Virgilio F, Pizzo P, Zanovello P, et al. Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunol Today 1990; 11(8): 274–7

    Article  PubMed  Google Scholar 

  59. Zanovello P, Bronte V, Rosato A, et al. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J Immunol 1990; 145(5): 1545–50

    CAS  Google Scholar 

  60. Avery RK, Bleier KJ, Pasternack MS. Differences between ATP-mediated cytotoxicity and cell-mediated cytotoxicity. J Immunol 1992; 149(4): 1265–70

    PubMed  CAS  Google Scholar 

  61. Correale P, Giuliano M, Tagliaferri P, et al. Role of adenosine 5′ triphosphate in lymphokine activated (LAK) killing of human tumor cells. Res Commun Mol Pathol Pharmacol 1995; 87(1): 67–9

    CAS  Google Scholar 

  62. Correale P, Tagliaferri P, Guarrasi R, et al. Extracellular adenosine 5′ triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation. Immunol Lett 1997; 55(2): 69–78

    Article  PubMed  CAS  Google Scholar 

  63. Filippini A, Taffs RE, Sitkovsky MV. Extracellular ATP in T-lymphocyte activation: possible role in effector functions. Proc Natl Acad Sci U S A 1990; 87(21): 8267–71

    Article  PubMed  CAS  Google Scholar 

  64. Di Virgilio F, Bronte V, Collavo D, et al. Responses of mouse lymphocytes to extracellular adenosine 5′-triphosphate (ATP): lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. J Immunol 1989; 143(6): 1955–60

    PubMed  Google Scholar 

  65. Filippini A, Sitkovsky MV. ‘Extracellular ATP’ hypothesis of cell-cell interactions in the effector phase of the immune response. FASEB J 1990; 4: A1870

    Google Scholar 

  66. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 1985; 16(5): 433–40

    Article  PubMed  CAS  Google Scholar 

  67. Houston DA, Burnstock G, Vanhoutte PM. Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther 1987; 241(2): 501–6

    PubMed  CAS  Google Scholar 

  68. Kennedy C, Burnstock G. ATP produces vasodilation via P1 purinoceptors and vasoconstriction via P2 purinoceptors in the isolated rabbit central ear artery. Blood Vessels 1985; 22(3): 145–55

    PubMed  CAS  Google Scholar 

  69. Boeynaems JM, Pearson JD. P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol Sci 1990; 11(1): 34–7

    Article  PubMed  CAS  Google Scholar 

  70. Utterback DB, Staples ED, White SE, et al. Basis for the selective reduction of pulmonary vascular resistance in humans during infusion of adenosine. J Appl Physiol 1994; 76(2): 724–30

    PubMed  CAS  Google Scholar 

  71. Boeynaems JM, Pirotton S, Van Coevorden A, et al. P2-purinergic receptors in vascular endothelial cells: from concept to reality. J Recept Res 1988; 8(1-4): 121–32

    PubMed  CAS  Google Scholar 

  72. Liu SF, McCormack DG, Evans TW, et al. Evidence for two P2-purinoceptor subtypes in human small pulmonary arteries. Br JPharmacol 1989; 98(3): 1014–20

    Article  CAS  Google Scholar 

  73. Fiscus RR. Molecular mechanisms of endothelium-mediated vasodilation. Semin Thromb Hemost 1988; 14 Suppl.: 12–22

    PubMed  Google Scholar 

  74. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. CircRes 1989; 65(1): 1–21

    CAS  Google Scholar 

  75. Belardinelli L, Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983; 244(5): H734–7

    PubMed  CAS  Google Scholar 

  76. Belardinelli L, Giles WR, West A. Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol (Lond) 1988; 405: 615–33

    CAS  Google Scholar 

  77. de Jong JW, van der Meer P, van Loon H, et al. Adenosine as adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. JThorac Cardiovasc Surg 1990; 100(3): 445–54

    Google Scholar 

  78. Freilich A, Tepper D. Adenosine and its cardiovascular effects. Am Heart J 1992; 123(5): 1324–8

    Article  PubMed  CAS  Google Scholar 

  79. Zhang C. Electrophysiological effects of different dosage of adenosine triphosphate on normal sinoatrial and atrioventricular node. Chung Hua Hsin Hsueh Kuan Ping Tsa Chih 1992; 20(2): 98–100, 134

    PubMed  CAS  Google Scholar 

  80. Kurachi Y, Nakajima T, Sugimoto T. On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflugers Arch 1986; 407(3): 264–74

    Article  PubMed  CAS  Google Scholar 

  81. Wayne EJ, Goodwin JF, Stoner HB. The effect of adenosine triphosphate on the electrocardiogram of man and animals. Br Heart J 1949; 11: 55–67

    Article  PubMed  CAS  Google Scholar 

  82. Munoz A, Leenhardt A, Sassine A, et al. Atropine antagonizes the effect of adenosine on atrioventricular conduction in closed chest dogs. Circulation 1985; 72(III): 241

    Google Scholar 

  83. Tai CT, Chen SA, Chiang CE, et al. Influence of beta-adrenergic and vagal activity on the effect of exogenous adenosine on supraventricular tachycardia termination. AmJCardiol 1997; 79(12): 1628–31

    Article  CAS  Google Scholar 

  84. DiMarco JP, Sellers TD, Berne RM, et al. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 1983; 68(6): 1254–63

    Article  Google Scholar 

  85. Faulds D, Chrisp P, Buckley MM. Adenosine: an evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs 1991; 41(4): 596–624

    Article  PubMed  CAS  Google Scholar 

  86. Charest R, Blackmore PF, Exton JH. Characterization of responses of isolated rat hepatocytes to ATP and ADR. J Biol Chem 1985; 260(29): 15789–94

    PubMed  CAS  Google Scholar 

  87. Okajima F, Tokumitsu Y, Kondo Y, et al. P2-purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes. J Biol Chem 1987; 262(28): 13483–90

    PubMed  CAS  Google Scholar 

  88. Boynton AL, Cooney RV, Hill TD, et al. Extracellular ATP mobilizes intracellular Ca2+ in T51B rat liver epithelial cells: a study involving single cell measurements. Exp Cell Res 1989; 181(1): 245–55

    Article  PubMed  CAS  Google Scholar 

  89. Dixon CJ, Woods NM, Cuthbertson KS, et al. Evidence for two Ca2+-mobilizing purinoceptors on rat hepatocytes. Biochem J 1990; 269(2): 499–502

    PubMed  CAS  Google Scholar 

  90. Cha SH, Jung KY, Endou H. Effect of P2Y-purinoceptor stimulation on renal gluconeogenesis in rats. Biochem Biophys Res Commun 1995; 211(2): 454–61

    Article  PubMed  CAS  Google Scholar 

  91. Koike M, Kashiwagura T, Takeguchi N. Gluconeogenesis stimulated by extracellular ATP is triggered by the initial increase in the intracellular Ca2 concentration of the periphery of hepatocytes. Biochem J 1992; 283(1): 265–72

    PubMed  CAS  Google Scholar 

  92. Saggerson ED, Carpenter CA, Veiga JA. Stimulation of renal gluconeogenesis by exogenous adenine nucleotides. Biochim Biophys Acta 1983; 755(1): 119–26

    Article  PubMed  CAS  Google Scholar 

  93. Edgecombe M, Craddock HS, Smith DC, et al. Diadenosine polyphosphate-stimulated gluconeogenesis in isolated rat proximal tubules. Biochem J 1997; 323 (Pt 2): 451–6

    PubMed  CAS  Google Scholar 

  94. Asensi M, Lopez-Rodas A, Sastre J, et al. Inhibition of gluconeogenesis by extracellular ATP in isolated rat hepatocytes. Am JPhysiol 1991; 261(6): R1522–6

    CAS  Google Scholar 

  95. Lund P, Cornell NW, Krebs HA. Effect of adenosine on the adenine nucleotide content and metabolism of hepatocytes. Biochem J 1975; 152(3): 593–9

    PubMed  CAS  Google Scholar 

  96. Creba JA, Downes CP, Hawkins PT, et al. Rapid breakdown of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate in rat hepatocytes stimulated by vasopressin and other Ca2+-mobilizing hormones. Biochem J 1983; 212(3): 733–47

    PubMed  CAS  Google Scholar 

  97. Keppens S, De Wulf H. Characterization of the liver P2-purinoceptor involved in the activation of glycogen phosphorylase. Biochem J 1986; 240(2): 367–71

    PubMed  CAS  Google Scholar 

  98. Keppens S, Vandekerckhove A, De Wulf H. Extracellular ATP and UTP exert similar effects on rat isolated hepatocytes. Br J Pharmacol 1992; 105(2): 475–9

    Article  PubMed  CAS  Google Scholar 

  99. Buxton DB, Robertson SM, Olson MS. Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver. Biochem J 1986; 237(3): 773–80

    PubMed  CAS  Google Scholar 

  100. Rapaport E. Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 1983; 114(3): 279–83

    Article  PubMed  CAS  Google Scholar 

  101. Roding TJ. De invloed van ATP op in-vitro gekweekte RUC (I) tumorcellen [thesis]. Amsterdam Free University 1977; (Ch. 3): 35–54

  102. Spungin B, Friedberg I. Growth inhibition of breast cancer cells induced by exogenous ATP. J Cell Physiol 1993; 157(3): 502–8

    Article  PubMed  CAS  Google Scholar 

  103. Weisman GA, Lustig KD, Lane E, et al. Growth inhibition of transformed mouse fibroblasts by adenine nucleotides occurs via generation of extracellular adenosine. J Biol Chem 1988; 263(25): 12367–72

    PubMed  CAS  Google Scholar 

  104. Lasso de la Vega MC, Terradez P, Obrador E, et al. Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP. Biochem J 1994; 298(1): 99–105

    PubMed  CAS  Google Scholar 

  105. Estrela JM, Obrador E, Navarro J, et al. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays. Nat Med 1995; 1(1): 84–8

    Article  PubMed  CAS  Google Scholar 

  106. Obrador E, Navarro J, Mompo J, et al. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Biochem J 1997; 325(1): 183–9

    PubMed  CAS  Google Scholar 

  107. Friedberg I, Kuebler D. The role of surface protein kinase in the ATP-induced growth inhibition in transformed mouse fibroblasts. Ann N Y Acad Sci 1990; 603: 513–5

    Article  Google Scholar 

  108. Friedberg I, Beizer I, Oged-Plesz O, et al. Activation of cell growth inhibitor by ectoprotein kinase-mediated phosphorylation in transformed mouse fibroblasts. J Biol Chem 1995; 270(35): 20560–7

    Article  PubMed  CAS  Google Scholar 

  109. Rozengurt E, Heppel LA, Friedberg I. Effect of exogenous ATP on the permeability properties of transformed cultures of mouse cell lines. J Biol Chem 1977; 252(13): 4584–90

    PubMed  CAS  Google Scholar 

  110. Dicker P, Heppel LA, Rozengurt E. Control of membrane permeability by external and internal ATP in 3T6 cells grown in serum-free medium. Proc Natl Acad Sci U S A 1980; 77(4): 2103–7

    Article  PubMed  CAS  Google Scholar 

  111. Heppel LA, Weisman GA, Friedberg I. Permeabilization of transformed cells in culture by external ATP. J Membr Biol 1985; 86(3): 189–96

    Article  PubMed  CAS  Google Scholar 

  112. Kitagawa T, Amano F, Akamatsu Y. External ATP-induced passive permeability change and cell lysis of cultured transformed cells: action in serum-containing growth media. Biochim Biophys Acta 1988; 941(2): 257–63

    Article  PubMed  CAS  Google Scholar 

  113. Kitagawa T, Akamatsu Y, Control of membrane permeability by external ATP in mammalian cells: isolation of an ATP-resistant variant from Chinese hamster ovary cells. Biochim Biophys Acta 1986; 860(2): 185–93

    Article  PubMed  CAS  Google Scholar 

  114. Mure T, Sano K, Kitagawa T. Modulation of membrane permeability, cell proliferation and cytotoxicity of antitumor agents by external ATP in mouse tumor cells. Jpn J Cancer Res 1992; 83(1): 121–6

    Article  PubMed  CAS  Google Scholar 

  115. Di Virgilio F, Fasolato C, Steinberg TH. Inhibitors of membrane transport system for organic anions block fura-2 excretion from PC12 and N2A cells. Biochem J 1988; 256(3): 959–63

    PubMed  Google Scholar 

  116. Bear CE, Li CH. Calcium-permeable channels in rat hepatoma cells are activated by extracellular nucleotides. Am J Physiol 1991; 261(6): C1018–24

    PubMed  CAS  Google Scholar 

  117. Nagelkerke JF, Dogterom P, De Bont HJ, et al. Prolonged high intracellular free calcium concentrations induced by ATP are not immediately cytotoxic in isolated rat hepatocytes: changes in biochemical parameters implicated in cell toxicity. Biochem J 1989; 263(2): 347–53

    PubMed  CAS  Google Scholar 

  118. Zoeteweij JP, van de Water B, de Bont HJ, et al. Calcium-induced cytotoxicity in hepatocytes after exposure to extra-cellular ATP is dependent on inorganic phosphate: effects on mitochondrial calcium. J Biol Chem 1993; 268(5): 3384–8

    PubMed  CAS  Google Scholar 

  119. Chahwala SB, Cantley LC. Extracellular ATP induces ion fluxes and inhibits growth of Friend erythroleukemia cells. J Biol Chem 1984; 259(22): 13717–22

    PubMed  CAS  Google Scholar 

  120. Zheng LM, Zychlinsky A, Liu CC, et al. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991; 112(2): 279–88

    Article  PubMed  CAS  Google Scholar 

  121. Wiley JS, Dubyak GR. Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood 1989; 73(5): 1316–23

    PubMed  CAS  Google Scholar 

  122. Wiley JS, Jamieson GP, Mayger W, et al. Extracellular ATP stimulates an amiloride-sensitive sodium influx in human lymphocytes. Arch Biochem Biophys 1990; 280(2): 263–8

    Article  PubMed  CAS  Google Scholar 

  123. Wiley JS, Chen R, Wiley MJ, et al. The ATP4-receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions. Arch Biochem Biophys 1992; 292(2): 411–8

    Article  PubMed  CAS  Google Scholar 

  124. Kitagawa T, Akamatsu Y. Modulation of passive permeability by external ATP and cytoskeleton-attacking agents in cultured mammalian cells. BiochimBiophys Acta 1983; 734(1): 25–32

    Article  CAS  Google Scholar 

  125. Franseschi C, Abbracchio MP, Barbieri D, et al. Purines and cell death. Drug Dev Res 1996; 39: 442–9

    Article  Google Scholar 

  126. Surprenant A, Rassendren F, Kawashima E, et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272(5262): 735–8

    Article  PubMed  CAS  Google Scholar 

  127. Spranzi E, Djeu JY, Hoffman SL, et al. Lysis of human monocytic leukemia cells by extracellular adenosine triphosphate: mechanism and characterization of the adenosine triphosphate receptor. Blood 1993; 82(5): 1578–85

    PubMed  CAS  Google Scholar 

  128. Blanchard DK, Hoffman SL, Spranzi E, et al. Killing of human acute myeloid leukemia cells by extracellular ATP: partial characterization of the ATP receptor. Proc Am Assoc Cancer Res 1994; 35(2273): 381

    Google Scholar 

  129. Bretschneider F, Klapperstuck M, Lohn M, et al. Nonselective cationic currents elicited by extracellular ATP in human B-lymphocytes. Pflugers Arch 1995; 429(5): 691–8

    Article  PubMed  CAS  Google Scholar 

  130. Seetulsingh-Goorah SP, Stewart BW. Extracellular ATP exerts antileukemic effects via a novel P2X receptor. Proc Am Assoc Cancer Res 1998; 39(449): 66

    Google Scholar 

  131. Kaiho H, Matsuoka I, Kimura J, et al. Identification of P2X7 (P2Z) receptor in N18TG-2 cells and NG108-15 cells. J Neurochem 1998; 70(3): 951–7

    Article  PubMed  CAS  Google Scholar 

  132. Chiozzi P, Murgia M, Falzoni S, et al. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem Biophys Res Commun 1996; 218(1): 176–81

    Article  PubMed  CAS  Google Scholar 

  133. Saribas AS, Lustig KD, Zhang X, et al. Extracellular ATP reversibly increases the plasma membrane permeability of transformed mouse fibroblasts to large macromolecules. Anal Biochem 1993; 209(1): 45–52

    Article  PubMed  CAS  Google Scholar 

  134. Beyer EC, Steinberg TH. Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. J Biol Chem 1991; 266(13): 7971–4

    PubMed  CAS  Google Scholar 

  135. Loewenstein WR. The cell-to-cell channel of gap junctions. Cell 1987; 48(5): 725–6

    Article  PubMed  CAS  Google Scholar 

  136. Alves LA, Coutinho-Silva R, Persechini PM, et al. Are there functional gap junctions or junctional hemichannels in macrophages? Blood 1996; 88(1): 328–34

    PubMed  CAS  Google Scholar 

  137. Nees S, Gerbes AL, Willershausen-Zonnchen B, et al. Purine metabolism in cultured coronary endothelial cells. Adv Exp Med Biol 1979; 122B: 25–30

    Article  PubMed  CAS  Google Scholar 

  138. Zhou X, Zhai X, Ashraf M. Preconditioning of bovine endothelial cells. The protective effect is mediated by an adenosine A2 receptor through a protein kinase C signaling pathway. Circ Res 1996; 78(1): 73–81

    CAS  Google Scholar 

  139. Bouma MG, Jeunhomme TM, Boyle DL, et al. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol 1997; 158(11): 5400–8

    PubMed  CAS  Google Scholar 

  140. Newby AC. Adenosine and the concept of retaliatory metabolites. Trends Biochem Sci 1984; 9: 42–4

    Article  CAS  Google Scholar 

  141. Bouma MG, van den Wildenberg FA, Buurman WA. The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: established and putative beneficial actions of a retaliatory metabolite. Shock 1997; 8(5): 313–20

    Article  PubMed  CAS  Google Scholar 

  142. Wang P, Zhou M, Rana MW, et al. ATP-MgCl2 restores renal microcirculation following trauma and severe hemorrhage. Can J Physiol Pharmacol 1992; 70(3): 349–57

    Article  PubMed  CAS  Google Scholar 

  143. Chaudry IH, Stephan RN, Dean RE, et al. Use of magnesium-ATP following liver ischemia. Magnesium 1988; 7: 68–77

    PubMed  CAS  Google Scholar 

  144. Hirasawa H, Chaundry IH, Baue AE. Improved hepatic function and survival with adenosine triphosphate-magnesium chloride after hepatic ischemia. Surgery 1978; 83(6): 655–62

    PubMed  CAS  Google Scholar 

  145. Hirasawa H, Ohkawa M, Odaka M, et al. Improved survival, RES function, and ICG test with ATP-MgCl2 following hepatic ischemia. Surg Forum 1979; 30: 158–60

    PubMed  CAS  Google Scholar 

  146. Wang P, Ba ZF, Chaudry IH. Differential effects of ATP-MgCl2 on portal and hepatic arterial blood flow after hemorrhage and resuscitation. Am J Physiol 1992; 263(6): G895–900

    PubMed  CAS  Google Scholar 

  147. Wang P, Ba ZF, Chaudry IH. ATP-MgCl2 restores the depressed cardiac output following trauma and severe hemorrhage even in the absence of blood resuscitation. Circ Shock 1992; 36(4): 277–83

    PubMed  CAS  Google Scholar 

  148. Chaudry IH, Sayeed MM, Baue AE. Depletion and restoration of tissue ATP in hemorrhagic shock. Arch Surg 1974; 108(2): 208–11

    Article  PubMed  CAS  Google Scholar 

  149. Ohkawa M, Clemens MG, Chaudry IH. Studies on the mechanism of beneficial effects of ATP-MgC12 following hepatic ischemia. Am J Physiol 1983; 244(5): R695–702

    PubMed  CAS  Google Scholar 

  150. Chaudry IH, Ohkawa M, Clemens MG. Improved mitochondrial function following ischemia and reflow by ATP-MgCl2. Am J Physiol 1984; 246(5): R799–804

    PubMed  CAS  Google Scholar 

  151. Wohlgelernter D, Jaffe C, Clements M. Effects of ATP-MgCl2 on coronary blood flow and myocardial oxygen consumption. Circulation 1985; 72: 311–5

    Google Scholar 

  152. Mahmoud MS, Wang P, Hootman SR, et al. ATP-MgCl2 treatment after trauma-hemorrhage/resuscitation increases hepatocyte P2-purinoceptor binding capacity. Am J Physiol 1994; 266(6): R1810–5

    PubMed  CAS  Google Scholar 

  153. Mahmoud MS, Wang P, Chaudry IH. Salutary effects of ATP-MgCl2 on altered hepatocyte signal transduction after hemorrhagic shock. Am J Physiol 1997; 272(6): G1347–54

    PubMed  CAS  Google Scholar 

  154. Maggirwar SB, Dhanraj DN, Somani SM, et al. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 1994; 201(2): 508–15

    Article  PubMed  CAS  Google Scholar 

  155. Ramkumar V, Nie Z, Rybak LP, et al. Adenosine, antioxidant enzymes and cytoprotection. Trends Pharmacol Sci 1995; 16(9): 283–5

    Article  PubMed  CAS  Google Scholar 

  156. Wang P, Ba ZF, Morrison MH, et al. Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: downregulation of inflammatory cytokine (TNF, IL-6) release. J Surg Res 1992; 52(4): 364–71

    Article  PubMed  CAS  Google Scholar 

  157. Bouma MG, Stad RK, van den Wildenberg FA, et al. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994; 153(9): 4159–68

    PubMed  CAS  Google Scholar 

  158. Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996; 270(2): C522–9

    PubMed  CAS  Google Scholar 

  159. Krump E, Lemay G, Borgeat P. Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo. Br J Pharmacol 1996; 117(8): 1639–44

    Article  PubMed  CAS  Google Scholar 

  160. Lappin D, Whaley K. Adenosine A2 receptors on human monocytes modulate C2 production. Clin Exp Immunol 1984; 57(2): 454–60

    PubMed  CAS  Google Scholar 

  161. Cronstein BN, Levin RI, Belanoff J, et al. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986; 78(3): 760–70

    Article  PubMed  CAS  Google Scholar 

  162. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92(6): 2675–82

    CAS  Google Scholar 

  163. Gomaa AA. Characteristics of analgesia induced by adenosine triphosphate. Pharmacol Toxicol 1987; 61(3): 199–202

    Article  PubMed  CAS  Google Scholar 

  164. Scitz PA, ter Riet M, Rush W, et al. Adenosine decreases the minimum alveolar concentration of halothane in dogs. Anesthesiology 1990; 73(5): 990–4

    Article  Google Scholar 

  165. Segerdahl M, Ekblom A, Sjolund KF, et al. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. Neuroreport 1995; 6(5): 753–6

    Article  PubMed  CAS  Google Scholar 

  166. Segerdahl M, Ekblom A, Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth Analg 1994; 79(4): 787–91

    Article  PubMed  CAS  Google Scholar 

  167. Segerdahl M, Ekblom A, Sandelin K, et al. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg 1995; 80(6): 1145–9

    PubMed  CAS  Google Scholar 

  168. Segerdahl M, Irestedt L, Sollevi A. Antinociceptive effect of perioperative adenosine infusion in abdominal hysterectomy. Acta Anaesthesiol Scand 1997; 41(4): 473–9

    Article  PubMed  CAS  Google Scholar 

  169. Beifrage M, Sollevi A, Segerdahl M, et al. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 1995; 81(4): 713–7

    Google Scholar 

  170. Sollevi A, Belfrage M, Lundeberg T, et al. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain 1995; 61(1): 155–8

    Article  PubMed  CAS  Google Scholar 

  171. Filkins JP, Buchanan BJ. Protection against endotoxin shock and impaired glucose homeostasis with ATP. Circ Shock 1977; 4(3): 253–8

    PubMed  CAS  Google Scholar 

  172. Zaki MS, Burke JF, Trelstad RL. Protective effects of adenosine triphosphate administration in burns. Arch Surg 1978; 113(5): 605–10

    Article  PubMed  CAS  Google Scholar 

  173. Cikrit D, Gross K, Katz S. Comparative effects of cytoprotective agents in bowel ischemia. Surg Forum 1983; 34: 208–10

    CAS  Google Scholar 

  174. Chaudry IH. Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983; 245(2): R117–34

    PubMed  CAS  Google Scholar 

  175. Chaudry IH. Use of ATPfollowing shock and ischemia [discussion 140-1]. Ann N Y Acad Sci 1990; 603: 130–40

    Article  PubMed  CAS  Google Scholar 

  176. Chaudry IH, Sayeed MM, Baue AE. Evidence for enhanced uptake of ATP by liver and kidney in hemorrhagic shock. Am J Physiol 1977; 233(3): R83–8

    PubMed  CAS  Google Scholar 

  177. Osias MD, Siegel NJ, Chaudry IH, et al. Postischemic renal failure: accelerated recovery with adenosine triphosphate-magnesium chloride infusion. Arch Surg 1977; 112: 729–31

    Article  PubMed  CAS  Google Scholar 

  178. Chaudry IH, Clemens MG, Ohkawa M, et al. Restoration of hepatocellular function and blood flow following hepatic ischemia with ATP-MgCK Adv Shock Res 1982; 8: 177–86

    PubMed  CAS  Google Scholar 

  179. McGovern PJ, Machiedo GW, Rush Jr BE. Hemodynamic effects of ATP-MgCl2 following shock. Curr Surg 1982; 39(2): 82–4

    PubMed  CAS  Google Scholar 

  180. Kopf GS, Chaudry I, Condos S, et al. Reperfusion with ATP-MgCl2 following prolonged ischemia improves myocardial performance. J Surg Res 1987; 43(2): 114–7

    Article  PubMed  CAS  Google Scholar 

  181. Jellinek M, Shapiro MJ, Villarreal-Loor B, et al. Therestoration of the phosphoinositide pool in hemorrhagic shock by ATP-MgCl2 and/or inositol in rabbit lung. Circ Shock 1988; 24: 274

    Google Scholar 

  182. Singh G, Chaudry KI, Chaudry IH. ATP-MgCl2 restores gut absorptive capacity early after trauma-hemorrhagic shock. Am J Physiol 1993; 264(5): R977–83

    PubMed  CAS  Google Scholar 

  183. Hirasawa H, Soeda K, Ohkawa M. A randomized clinical trial of ATP-MgCb for post-ischemic acute renal failure. Circ Shock 1985; 13: 66

    Google Scholar 

  184. Davies DF, Gropper AL, Schroeder HA. Circulatory and respiratory effects of adenosine triphosphate in man. Circulation 1951; ni: 543–50

    Article  Google Scholar 

  185. Fukunaga AF, Kaneko Y, Ichinohe T, et al. Intravenous ATP attenuates surgical stress responses and reduces inhalation anesthetic requirements in humans. Anesthesiology 1990; 73(3A): A400

    Google Scholar 

  186. Coli A, Fabbri G, Lari S, et al. Hypotension controlled with ATP in orthopaedic surgery: incidence of atrio-ventricular conduction disorders. Minerva Anestesiol 1994; 60(1–2): 21–7

    PubMed  CAS  Google Scholar 

  187. Owall A, Jarnberg PO, Brodin LA, et al. Effects of adenosine-induced hypotension on myocardial hemodynamics and metabolism in fentanyl anesthetized patients with peripheral vascular disease. Anesthesiology 1988; 68(3): 416–21

    Article  PubMed  CAS  Google Scholar 

  188. Owall A, Sollevi A. Myocardial effects of adenosine- and sodium nitroprusside-induced hypotension: a comparative study in patients anaesthetized for abdominal aortic aneurysm surgery. Acta Anaesthesiol Scand 1991; 35(3): 216–20

    Article  PubMed  CAS  Google Scholar 

  189. Sollevi A, Lagerkranser M, Irestedt L, et al. Controlled hypotension with adenosine in cerebral aneurysm surgery. Anesthesiology 1984; 61(4): 400–5

    Article  PubMed  CAS  Google Scholar 

  190. Owall A, Gordon E, Lagerkranser M, et al. Clinical experience with adenosine for controlled hypotension during cerebral aneurysm surgery. Anesth Analg 1987; 66(3): 229–34

    PubMed  CAS  Google Scholar 

  191. Owall A, Lagerkranser M, Sollevi A. Effects of adenosine-induced hypotension on myocardial hemodynamics and metabolism during cerebral aneurysm surgery. Anesth Analg 1988; 67(3): 228–32

    PubMed  CAS  Google Scholar 

  192. Lagerkranser M, Bergstrand G, Gordon E, et al. Cerebral blood flow and metabolism during adenosine-induced hypotension in patients undergoing cerebral aneurysm surgery. Acta Anaesthesiol Scand 1989; 33(1): 15–20

    Article  PubMed  CAS  Google Scholar 

  193. Fukunaga AF, Ikeda K, Matsuda I. ATP-induced hypotensive anesthesia during surgery. Anesthesiology 1982; 57(3): A65

    Article  Google Scholar 

  194. Fukunaga AF, Sodeyama O, Matsuzaki Y, et al. Hemodynamic and metabolic changes of ATP-induced hypotension during surgery. Anesthesiology 1983; 59(3): A12

    Google Scholar 

  195. Colson P, Saussine M, Gaba S, et al. Vascular effects of adenosine-triphosphate. Ann Fr Anesth Reanim 1991; 10(3): 251–4

    Article  PubMed  CAS  Google Scholar 

  196. Segerdahl M, Persson E, Ekblom A, et al. Peroperative adenosine infusion reduces isoflurane concentrations during general anesthesiafor shoulder surgery. Acta Anaesthesiol Scand 1996; 40(7): 792–7

    Article  PubMed  CAS  Google Scholar 

  197. Aso Y, Tajima A, Suzuki K, et al. Intraoperative blood pressure control by ATP in pheochromocytoma. Urology 1986; 27(6): 512–20

    Article  PubMed  CAS  Google Scholar 

  198. Bindslev L, Sollevi A, Groendal S, et al. Adenosine:a new drug for blood pressure control during pheochromocytoma removal. Acta Anaesthesiol Scand Suppl 1987; 86(31): 109

    Google Scholar 

  199. Grondai S, Bindslev L, Sollevi A, et al. Adenosine: a new anti-hypertensive agent during pheochromocytoma removal. World J Surg 1988; 12(5): 581–5

    Article  Google Scholar 

  200. Torssell L, Ekestrom S, Sollevi A. Adenosine-induced increase in graft flow during coronary bypass surgery. Scand J Thorac Cardiovasc Surg 1989; 23(3): 235–9

    Article  PubMed  CAS  Google Scholar 

  201. Rubin LJ. Vasodilators and pulmonary hypertension: where do we go from here? Am Rev Respir Dis 1987; 134: 287

    Google Scholar 

  202. Gaba SJ, Prefaut C. Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease. ATP: a pulmonary controlled vasoregulator? Eur Respir J 1990; 3(4): 450–5

    CAS  Google Scholar 

  203. Fullerton DA, Jaggers J, Jones SD, et al. Adenosine for refractory pulmonary hypertension. Ann Thorac Surg 1996; 62(3): 874–7

    PubMed  CAS  Google Scholar 

  204. Paidas CN, Dudgeon DL, Haller Jr JA, et al. Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg 1988; 23(12): 1154–60

    Article  PubMed  CAS  Google Scholar 

  205. Fineman JR, Crowley MR, Soifer SJ. Selective pulmonary vasodilation with ATP-MgCl2 during pulmonary hypertension in lambs. J Appl Physiol 1990; 69(5): 1836–42

    PubMed  CAS  Google Scholar 

  206. Konduri GG, Theodorou AA, Mukhopadhyay A, et al. Adenosine triphosphate and adenosine increase the pulmonary blood flow to postnatal levels in fetal lambs. Pediatr Res 1992; 31(5): 451–7

    Article  PubMed  CAS  Google Scholar 

  207. Paidas CN, Dudgeon DL, Haller Jr JA, et al. Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension (HPH): comparison of dose dependence in pulmonary and renal circulations. J Surg Res 1989; 46(4): 374–9

    Article  PubMed  CAS  Google Scholar 

  208. Kaapa P, Jahnukainen T, Gronlund J, et al. Adenosine triphosphate treatment for meconium aspiration-induced pulmonary hypertension in pigs. Acta Physiol Scand 1997; 160(3): 283–9

    Article  PubMed  CAS  Google Scholar 

  209. Reid PG, Fraser AG, Watt AH, et al. Acute haemodynamic effects of intravenous infusion of adenosine in conscious man. EurHeartJ 1990; 11(11): 1018–28

    CAS  Google Scholar 

  210. Gaba SJ, Bourgouin-Karaouni D, Dujols P, et al. Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator? Am Rev Respir Dis 1986; 134(6): 1140–4

    PubMed  CAS  Google Scholar 

  211. Gaba S, Didier C, Cohendy R, et al. Effects vasculaires pulmonaires et systemiques de l’ATP chez l’Homme. C R Seances Soc Biol Fil 1986; 180: 568–73

    PubMed  CAS  Google Scholar 

  212. Brook MM, Fineman JR, Bolinger AM, et al. UseofATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994; 90(3): 1287–93

    Article  PubMed  CAS  Google Scholar 

  213. Gerasimov NM, Guliamov DS, Karimova TZ, et al. Biologically active substances during treatment of pulmonary hypertension with ATP infusions immediately after general anesthesia and surgery of hypervolemic congenital heart defects. Anesteziol Reanimatol 1994 (3): 14–7

  214. Drury AN, Szent-Gyorgi A. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol (Lond) 1929; 68: 213–37

    CAS  Google Scholar 

  215. Jezer A, Oppenheimer BS, Schwartz SP. The effect of adenosine on cardiac irregularities in man. Am Heart J 1934; 9: 252–9

    Article  Google Scholar 

  216. Somlo E. Adenosine triphosphate in paroxysmal tachycardia. Lancet 1955; 1: 1125

    Article  Google Scholar 

  217. Rankin AC, Oldroyd KG, Chong E, et al. Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias. Am Heart J 1990; 119(2): 316–23

    Article  PubMed  CAS  Google Scholar 

  218. Sollevi A, Lagerkranser M, Andreen M, et al. Relationship between arterial and venous adenosine levels and vasodilatation during ATP and adenosine infusion in dogs. Acta Physiol Scand 1984; 120(2): 171–6

    Article  PubMed  CAS  Google Scholar 

  219. De Wolf D, Rondia G, Verhaaren H, et al. Adenosine triphosphate treatment for supraventricular tachycardia in infants. EurJ Pediatr 1994; 153(11): 793–6

    Article  Google Scholar 

  220. Gonzalez de Dios J, Burgueros Valero M, Garcia Guereta L, et al. Adenosine triphosphate (ATP) in the management of paroxysmal supraventricular tachycardia: experience in the neonatal. Rev Esp Cardiol 1995; 48(4): 260–5

    PubMed  CAS  Google Scholar 

  221. Clarke B, Till J, Rowland E, et al. Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet 1987; 1(8528): 299–301

    Article  PubMed  CAS  Google Scholar 

  222. Paret G, Steinmetz D, Kuint J, et al. Adenosine for the treatment of paroxysmal supraventricular tachycardia in full-term and preterm newborn infants. Am J Perinatol 1996; 13(6): 343–6

    Article  PubMed  CAS  Google Scholar 

  223. Belhassen B, Glick A, Laniado S. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia. Circulation 1988; 77(4): 795–805

    Article  PubMed  CAS  Google Scholar 

  224. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med 1990; 113(2): 104–10

    PubMed  CAS  Google Scholar 

  225. Viskin S, Belhassen B, Sheps D, et al. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate. Am J Cardiol 1992; 70(9): 879–85

    Article  PubMed  CAS  Google Scholar 

  226. Roig Garcia JJ, Jimenez Murillo LM, Clemente Millan MJ, et al. The clinical usefulness and efficacy of adenosine triphosphate in an emergency service. Rev Clin Esp 1994; 194(8): 594–8

    PubMed  CAS  Google Scholar 

  227. Sethi KK, Singh B, Kalra GS, et al. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Indian Heart J 1994; 46(3): 141–4

    PubMed  CAS  Google Scholar 

  228. Strickberger SA, Man KC, Daoud EG, et al. Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med 1997; 127(6): 417–22

    PubMed  CAS  Google Scholar 

  229. Gil Madre J, Lazaro Rodriguez S, Sentenac Merchan G, et al. Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: a comparison with verapamil. Rev Esp Cardiol 1995; 48(1): 55–8

    PubMed  CAS  Google Scholar 

  230. Madsen CD, Pointer JE, Lynch TG. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting. Ann Emerg Med 1995; 25(5): 649–55

    Article  PubMed  CAS  Google Scholar 

  231. Ferreira JF, Pamplona D, Cesar LA, et al. Comparative study between verapamil and adenosine triphosphate in the treatment of paroxysmal supraventricular tachycardia. Arq Bras Cardiol 1996; 66(2): 55–7

    PubMed  CAS  Google Scholar 

  232. Brady Jr WJ, DeBehnke DJ, Wickman LL, et al. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med 1996; 3(6): 574–85

    Article  PubMed  Google Scholar 

  233. Munoz A, Leenhardt A, Sassine A, et al. Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia. EurHeart J 1984; 5(9): 735–8

    CAS  Google Scholar 

  234. Brandao L, de Sousa J, Barreiros MC, et al. Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia [in Portuguese]. Rev Port Cardiol 1994; 13(3): 197–202, 191

    PubMed  CAS  Google Scholar 

  235. Rankin AC, Oldroyd KG, Chong E, et al. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. BrHeartJ 1989; 62(3): 195–203

    CAS  Google Scholar 

  236. Sharma AD, Klein GJ, Yee R. Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility. Am J Med 1990; 88(4): 337–43

    Article  PubMed  CAS  Google Scholar 

  237. Griffith MJ, Linker NJ, Ward DE, et al. Adenosine in the diagnosis of broad complex tachycardia. Lancet 1988; 1(8587): 672–5

    Article  PubMed  CAS  Google Scholar 

  238. Coyne E, Van de Streek P, Belvedere D, et al. A prospective study comparing thallium-201 imaging after intravenous adenosine infusion and exercise testing in the diagnosis of coronary artery disease. Eur J Nucl Med 1990; 16: S194

    Google Scholar 

  239. Verani MS, Mahmarian JJ, Hixson JB, et al. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990; 82(1): 80–7

    Article  PubMed  CAS  Google Scholar 

  240. Ferreira J, Gil VM, Ventosa A, et al. Effectiveness and safety of coronary vasodilation with adenosine triphosphate with thallium-201 for the diagnosis of coronary disease. Rev Port Cardiol 1995; 14(3): 215–24, 188

    PubMed  CAS  Google Scholar 

  241. Wang FP, Amanullah AM, Kiat H, et al. Diagnostic efficacy of stress technetium 99m-labelled sestamibi myocardial perfusion single-photon emission computed tomography in detection of coronary artery disease among patients over age 80. J Nucl Cardiol 1995; 2(5): 380–8

    Article  PubMed  CAS  Google Scholar 

  242. Amanullah AM, Berman DS, Hachamovitch R, et al. Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 1997; 80(2): 132–7

    Article  PubMed  CAS  Google Scholar 

  243. Vaduganathan P, He ZX, Raghavan C, et al. Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging? J Am Coll Cardiol 1996; 28(3): 543–50

    Article  PubMed  CAS  Google Scholar 

  244. Djordjevic-Dikic AD, Ostojic MC, Beleslin BD, et al. High dose adenosine stress echocardiography for noninvasive detection of coronary artery disease. J Am Coll Cardiol 1996; 28(7): 1689–95

    Article  PubMed  CAS  Google Scholar 

  245. Mahmarian JJ, Boyce TM, Goldberg RK, et al. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990; 15(2): 318–29

    Article  PubMed  CAS  Google Scholar 

  246. Boucher RC, Stutts MJ, Knowles MR, et al. Na+ transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 1986; 78(5): 1245–52

    Article  PubMed  CAS  Google Scholar 

  247. Puchelle E, de Bentzmann S, Zahm JM. Physical and functional properties of airway secretions in cystic fibrosis — therapeutic approaches. Respiration 1995; 62 Suppl. 1: 2–12

    Article  PubMed  CAS  Google Scholar 

  248. Lansley AB, Sanderson MJ, Dirksen ER. Control of the beat cycle of respiratory tract cilia by Ca2+ and cAMP. Am J Physiol 1992; 263(2): L232–42

    PubMed  CAS  Google Scholar 

  249. Kim KC, Lee BC. P2 purinoceptor regulation of mucin release by airway goblet cells in primary culture. Br J Pharmacol 1991; 103(1): 1053–6

    Article  PubMed  CAS  Google Scholar 

  250. Davis CW, Dowell ML, Lethem M, et al. Goblet cell degranulation in isolated canine tracheal epithelium: response to exogenous ATP, ADP, and adenosine. Am J Physiol 1992; 262(5): C1313–23

    PubMed  CAS  Google Scholar 

  251. Lethem MI, Dowell ML, Van Scott M, et al. Nucleotide regulation of goblet cells in human airway epithelial expiants: normal exocytosis in cystic fibrosis. Am J Respir Cell Mol Biol 1993; 9(3): 315–22

    PubMed  CAS  Google Scholar 

  252. Merten MD, Breittmayer JP, Figarella C, et al. ATP and UTP increase secretion of bronchial inhibitor by human tracheal gland cells in culture. Am J Physiol 1993; 265(5): L479–84

    PubMed  CAS  Google Scholar 

  253. Jiang C, Finkbeiner WE, Widdicombe JH, et al. Altered fluid transport across airway epithelium in cystic fibrosis. Science 1993; 262(5132): 424–7

    Article  PubMed  CAS  Google Scholar 

  254. Benali R, Pierrot D, Zahm JM, et al. Effect of extracellular ATP and UTP on fluid transport by human nasal epithelial cells in culture. Am J Respir Cell Mol Biol 1994; 10(4): 363–8

    PubMed  CAS  Google Scholar 

  255. Olivier KN, Bennett WD, Hohneker KW, et al. Acute safety and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate +/-amiloride in normal human adults. Am J Respir Crit Care Med 1996; 154(1): 217–23

    PubMed  CAS  Google Scholar 

  256. Knowles MR, Clarke LL, Boucher RC. Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest 1992; 101(3): 60S–3S

    Article  PubMed  CAS  Google Scholar 

  257. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15(2): 161–5

    Article  PubMed  CAS  Google Scholar 

  258. Bennett WD, Olivier KN, Zeman KL, et al. Effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 1996; 153(6): 1796–801

    PubMed  CAS  Google Scholar 

  259. Knowles MR, Church NL, Waltner WE, et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 1990; 322(17): 1189–94

    Article  PubMed  CAS  Google Scholar 

  260. Schneeberger AL, Thompson RT, Driedger AA, et al. Effect of cancer on the in vivo energy state of rat liver and skeletal muscle. Cancer Res 1989; 49(5): 1160–4

    PubMed  CAS  Google Scholar 

  261. Shaw JH, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer: the response to glucose infusion and parenteral feeding. Ann Surg 1987; 205(4): 368–76

    Article  PubMed  CAS  Google Scholar 

  262. Drott C, Persson H, Lundholm K. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer. Clin Physiol 1989; 9(5): 427–39

    Article  PubMed  CAS  Google Scholar 

  263. Lundholm K, Bylund AC, Holm J, et al. Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer 1976; 12(6): 465–73

    Article  PubMed  CAS  Google Scholar 

  264. Nixon DW, Heymsfield SB, Cohen AE, et al. Protein-calorie undernutrition in hospitalized cancer patients. Am J Med 1980; 68(5): 683–90

    Article  PubMed  CAS  Google Scholar 

  265. Shapot VS, Blinov VA. Blood glucose levels and gluconeogenesis in animals bearing transplantable tumors. Cancer Res 1974; 34(8): 1827–32

    PubMed  CAS  Google Scholar 

  266. Lundholm K, Edstrom S, Karlberg I, et al. Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer 1982; 50(6): 1142–50

    Article  PubMed  CAS  Google Scholar 

  267. Dagnelie PC, Bell JD, Williams SC, et al. Effect offish oil on cancer cachexia and host liver metabolism in rats with prostate tumors. Lipids 1994; 29(3): 195–203

    Article  PubMed  CAS  Google Scholar 

  268. Ovesen L, Allingstrup L, Hannibal J, et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993; 11(10): 2043–9

    PubMed  CAS  Google Scholar 

  269. Chlebowski RT, Palomares MR, Lillington L, et al. Recent implications of weight loss in lung cancer management. Nutrition 1996; 12(1): S43–7

    Article  PubMed  CAS  Google Scholar 

  270. Dagnelie PC, Bell JD, Barnard ML, et al. Potential of nuclear magnetic resonance spectroscopy for studies of n-3 fatty acid metabolism in plasma, liver and adipose tissue. Omega 1993; 3: 27–34

    Google Scholar 

  271. Tsuburaya A, Blumberg D, Burt M, et al. Energy depletion in the liver and in isolated hepatocytes of tumor-bearing animals. J Surg Res 1995; 59(4): 421–7

    Article  PubMed  CAS  Google Scholar 

  272. Haskell CM, Mendoza E, Pisters KM, et al. Phase II study of intravenous adenosine triphosphate (ATP) in patients with previously untreated stage TUB and stage IV non-small cell lung cancer. Invest New Drugs 1998; 16: 81–5

    Article  PubMed  CAS  Google Scholar 

  273. Fang WG, Pirnia F, Bang YJ, et al. P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 1992; 89(1): 191–6

    Article  PubMed  CAS  Google Scholar 

  274. Vandewalle B, Hornez L, Revillion F, et al. Effect of extracellular ATP on breast tumor cell growth, implication of intra-cellular calcium. Cancer Lett 1994; 85(1): 47–54

    Article  PubMed  CAS  Google Scholar 

  275. Hatta Y, Aizawa S, Horikoshi A, et al. Selective killing of murine leukemic cells by adenosine triphosphate (ATP): a study of the value of autologous bone marrow transplantation. Intern Med 1993; 32(10): 768–72

    Article  PubMed  CAS  Google Scholar 

  276. Hatta Y, Aizawa S, Itoh T, et al. Cytotoxic effect of extracellular ATP on L1210 leukemic cells and normal hemopoietic stem cells. Leuk Res 1994; 18(8): 637–41

    Article  PubMed  CAS  Google Scholar 

  277. Beizer I, Friedberg I. ATP-resistant variants of transformed mouse fibroblasts. J Cell Physiol 1989; 140(3): 524–9

    Article  Google Scholar 

  278. Roding TJ. De intra-arteriele toediening van ATP aan een bij de rat geimplanteerde tumor [thesis]. 1977; (Ch. 6): 71–92

  279. Nayak KK, Maity P, Bhattacharyya R, et al. Antitumor activities of copper-ATP complex on transplantable murine lymphoma. Pharmacology 1990; 41(6): 350–6

    Article  PubMed  CAS  Google Scholar 

  280. Froio J, Abraham EH, Soni R, et al. Effect of intraperitoneal ATP on tumor growth and bone marrow radiation tolerance. Acta Oncol 1995; 34(3): 419–22

    Article  PubMed  CAS  Google Scholar 

  281. Pal S, Nayak KK, Maity P. Investigation on phosphate dependent glutaminase (EC 3.5.1.2) activity in host tissues of EAC-bearing mice and response of liver EC 3.5.1.2 on Cu-ATP therapy. Cancer Lett 1991; 58(1-2): 151–3

    Article  PubMed  CAS  Google Scholar 

  282. Maymon R, Bar-Shira Maymon B, Cohen-Armon M, et al. Enhancing effect of ATP on intracellular adriamycin penetration in human ovarian cancer cell lines. Biochim Biophys Acta 1994; 1201(2): 173–8

    Article  PubMed  CAS  Google Scholar 

  283. Fishman P, Bar-Yehuda S. Extracellular adenosine acts as a chemoprotective agent. Proc Am Assoc Cancer Res 1998; 39(32): 3196

    Google Scholar 

  284. Baba T, Fukui M, Takeshita I, et al. Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate. J Neurosurg 1990; 72(6): 907–11

    Article  PubMed  CAS  Google Scholar 

  285. Szeinfeld D, de Villiers N. Response of normal B ALB/c mouse tissue to p (66 MeV)/Be fast neutron radiation: protection by exogenous ATP. Strahlenther Onkol 1992; 168(3): 174–8

    PubMed  CAS  Google Scholar 

  286. Szeinfeld D. The multifactorial role of ATP in repair processes and radioprotection. Med Hypotheses 1990; 32(3): 225–9

    Article  PubMed  CAS  Google Scholar 

  287. Szeinfeld D, Blekkenhorst G. Effect of X irradiation on adenosine triphosphate and glucose-6-phosphate dehydrogenase in the CaNT mouse tumor. Radiat Res 1987; 110(2): 305–9

    Article  PubMed  CAS  Google Scholar 

  288. Szeinfeld D, De Villiers N. Radioprotective properties of ATP and modification of acid phosphatase response after a lethal dose of whole body p (66MeV)/Be neutron radiation to B ALB/c mice. Cancer Biochem Biophys 1992; 13(2): 123–32

    PubMed  CAS  Google Scholar 

  289. Szeinfeld D, de Villiers N. Cholinesterase response in the rhabdomyosarcoma tumor and small intestine of the B ALB/c mice and the radioprotective actions of exogenous ATP after lethal dose of neutron radiation. Strahlenther Onkol 1993; 169(5): 311–6

    PubMed  CAS  Google Scholar 

  290. Lee JW, Filkins JP. Exogenous ATP and carbohydrate metabolism in the rat liver. Circ Shock 1987; 22(3): 205–19

    PubMed  CAS  Google Scholar 

  291. Nikolov I, Rogozkin VD, Pantev T, et al. Protection of monkeys against prolonged gamma-irradiation. Strahlenther Onkol 1986; 162(3): 200–4

    PubMed  CAS  Google Scholar 

  292. Tikhomirova MV, Iashkin PN, Fedorenko BS, et al. Radiation-protective effectiveness of ATP and adenosine against high-energy protons. Kosm Biol Aviakosm Med 1984; 18(5): 75–7

    PubMed  CAS  Google Scholar 

  293. Senagore AJ, Milsom JW, Walshaw RK, et al. Adenosine triphosphate-magnesium chloride in radiation injury. Surgery 1992; 112(5): 933–9

    PubMed  CAS  Google Scholar 

  294. Vorozhtsova SV, Fedorenko BS, Andrushchenko VN, et al. Biological effect of 9 GeV protons and the radioprotective effect of ATP and AMP on epithelial cells of the mouse cornea. Radiobiologiia 1987; 27(6): 779–83

    PubMed  CAS  Google Scholar 

  295. Perrot B, Clozel JP, Faivre G. Effect of adenosine triphosphate on the accessory pathways. Eur Heart J 1984; 5(5): 382–93

    PubMed  CAS  Google Scholar 

  296. Watt AH, Bernard MS, Webster J, et al. Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole. Br J Clin Pharmacol 1986; 21(2): 227–30

    Article  PubMed  CAS  Google Scholar 

  297. Biaggioni I, Olafsson B, Robertson RM, et al. Cardiovascular and respiratory effects of adenosine in conscious man: evidence for chemoreceptor activation. Circ Res 1987; 61(6): 779–86

    Article  PubMed  CAS  Google Scholar 

  298. Jonzon B, Sylven C, Beermann B, et al. Adenosine receptor mediated stimulation of ventilation in man. Eur J Clin Invest 1989; 19(1): 65–71

    Article  PubMed  CAS  Google Scholar 

  299. Conradson TB, Dixon CM, Clarke B, et al. Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole. Acta Physiol Scand 1987; 129(3): 387–91

    Article  PubMed  CAS  Google Scholar 

  300. Sylven C, Beermann B, Jonzon B, et al. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J 1986; 293(6541): 227–30

    Article  CAS  Google Scholar 

  301. Domanovits H, Laske H, Stark G, et al. Adenosine for the management of patients with tachycardias — a new protocol. Em-Heart J 1994; 15(5): 589–93

    Article  CAS  Google Scholar 

  302. Belhassen B, Pelleg A, Shoshani D, et al. Atrial fibrillation induced by adenosine triphosphate. Am J Cardiol 1984; 53(9): 1405–6

    Article  PubMed  CAS  Google Scholar 

  303. Watt AH, Reid PG, Stephens MR, et al. Adenosine-induced respiratory stimulation in man depends on site of infusion: evidence for an action on the carotid body? Br J Clin Pharmacol 1987; 23(4): 486–90

    Article  PubMed  CAS  Google Scholar 

  304. Sylven C. Angina pectoris-like pain provoked by intravenous infusion of adenosine. Br Med J 1986; 293(6556): 1240

    Article  CAS  Google Scholar 

  305. Sylven C, Jonzon B, Fredholm BB, et al. Adenosine injection into the brachial artery produces ischaemia like pain or discomfort in the forearm. Cardiovasc Res 1988; 22(9): 674–8

    Article  PubMed  CAS  Google Scholar 

  306. Sylven C, Beermann B, Edlund A, et al. Provocation of chest pain in patients with coronary insufficiency using the vasodilator adenosine. Eur Heart J 1988; 9 Suppl. N: 6–10

    Article  PubMed  Google Scholar 

  307. Sylven C. Mechanisms of pain in angina pectoris — a critical review of the adenosine hypothesis. Cardiovasc Drugs Ther 1993; 7(5): 745–59

    Article  PubMed  CAS  Google Scholar 

  308. Crea F, Pupita G, Galassi AR, et al. Role of adenosine in pathogenesis of anginal pain. Circulation 1990; 81(1): 164–72

    Article  PubMed  CAS  Google Scholar 

  309. Lagerqvist B, Sylven C, Theodorsen E, et al. Adenosine induced chest pain: a comparison between intracoronary bolus injection and steady state infusion. Cardiovasc Res 1992; 26(8): 810–4

    Article  PubMed  CAS  Google Scholar 

  310. Straat E, Henriksson P, Edlund A. Adenosine provokes myocardial ischaemia in patients with ischaemic heart disease without increasing cardiac work. J Intern Med 1991; 230(4): 319–23

    Article  PubMed  CAS  Google Scholar 

  311. O’Keefe Jr JH, Bateman TM, Silvestri R, et al. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J 1992; 124(3): 614–21

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II, Erasmus University Rotterdam, Rotterdam, The Netherlands

    Hendrik J. Agteresch,  Pieter C. Dagnelie, J. Willem O. van den Berg & J. H. Paul Wilson

  2. Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands

    Pieter C. Dagnelie

Authors
  1. Hendrik J. Agteresch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pieter C. Dagnelie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Willem O. van den Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. H. Paul Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agteresch, H.J., Dagnelie, P.C., van den Berg, J.W.O. et al. Adenosine Triphosphate. Drugs 58, 211–232 (1999). https://doi.org/10.2165/00003495-199958020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958020-00002

Search

Navigation